Veradigm | MDRX - Passivo Circulante





Passivo Circulante Alterar Data
Alcidion AUD 22.33M 1.47M 2025-12
Ambu A/S DKK 1.11B 76M 2026-06
Amplifon EUR 738.21M 852.39M 2026-06
Cardinal Health USD 43.9B 1.92B 2026-06
Centene USD 40.76B 714M 2026-06
Charles River Laboratories USD 1.13B 41.04M 2026-06
Cigna USD 55.56B 2.96B 2026-06
Coloplast 7.93B 1.42B 2025-12
Convatec Group USD 512.3M 130.7M 2024-12
CVS Health USD 87.04B 635M 2026-06
Diasorin EUR 555.45M 289.08M 2025-06
Elevance Health USD 44.25B 1.06B 2026-06
General Electric Aerospace USD 40.43B 403M 2026-06
Gulf Medical Proj AED 299.43M 128.34M 2026-03
Humana USD 21.51B 5.16B 2026-03
IQVIA Holdings USD 8.82B 486M 2026-06
Laboratory Of America USD 2.12B 516.4M 2026-06
Maximus USD 678.07M 3.62M 2026-06
McKesson USD 70.36B 3.34B 2026-06
Med Life RON 929.7M 46.35M 2026-03
Molina Healthcare USD 7.7B 488M 2026-06
Omnicell USD 447.44M 35.61M 2026-06
Oriola-kd EUR 649.7M 140.4M 2026-03
Owens Minor USD 666.22M 536.89M 2026-06
Quest Diagnostics USD 1.79B 389M 2026-06
Rede D'or Sao Luiz BRL 19.73B 605.8M 2026-06
Siemens Healthineers EUR 12.87B 11M 2026-06
Sonova Holding CHF 1.5B 303M 2025-06
Supermax Corporation Bhd MYR 335.77M 15.65M 2026-03
UnitedHealth USD 111.82B 2.3B 2026-06
Veeva Systems USD 1.46B 245.82M 2026-06
Veradigm USD 230.31M 22.78M 2022-12
Xerox USD 3.13B 76M 2026-06